• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

HLTH: CopilotIQ & Biofourmis Merge to Create AI-Driven Platform for In-Home Care

by Fred Pennic 10/21/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GE HealthCare, Biofourmis Partner to Enhance Patient Care with At-Home Solutions

What You Should Know: 

– CopilotIQ, a health tech company focused on improving the lives of older adults with chronic conditions, and Biofourmis, a global leader in technology-enabled home care solutions, have announced a strategic merger. 

– The combined company creates an AI-driven platform to deliver comprehensive in-home care across the entire care continuum, from pre-surgical optimization to acute, post-acute, and chronic care management. As part of this merger, investors from both businesses, including General Atlantic, Openspace Ventures, and Bessemer Venture Partners are investing into the combined business.

Addressing the Challenges of In-Home Care Delivery

Hospitals and payers face increasing pressure to deliver high-quality, cost-effective care in the home setting. However, managing multiple point solutions for different care needs creates complexity and fragmentation. This merger addresses these challenges by providing a single, integrated platform that streamlines in-home care delivery.

Benefits for Healthcare Organizations

The combined company offers several key advantages for healthcare organizations:

  • Comprehensive In-Home Care: Delivers a full spectrum of care, from pre-surgical optimization to chronic condition management, through a single vendor.
  • Unified Platform: Provides a “single pane of glass” solution for managing patients across the care continuum, simplifying technology integration and data management.
  • Enhanced Efficiency: Streamlines operations and reduces administrative burden by consolidating multiple point solutions into one platform.
  • Improved Patient Experience: Delivers a more coordinated and convenient care experience for patients.

“Our mission is to redefine the future of healthcare delivery, by extending care to the comfort of patients’ homes, and driving improved health outcomes, at the lowest possible cost to the system,” said David Koretz, CEO of CopilotIQ and Biofourmis, the newly combined entity. “This merger is a major step toward realizing our vision of transforming healthcare from reactive treatment to proactive prevention, and from generalized to deeply personalized, data-driven care.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions, Home Care, home health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |